Hypertrophic cardiomyopathy trials in Sweden

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Short and long-term Hemodynamic and Physiological Effects of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

  Where

  Lund, Solna

  Age

  18 years and over

  People

  40

  Run by

  Region Skane

  See details and how to join2025-524722-17-00 · EU 2025-524722-17-00
• No phaseEnrolling by invitation
  Sahlgrenska Cardiomyopathy Project

  Where

  Gothenburg

  Age

  18 years to 99 years

  People

  3,000

  Run by

  Göteborg University

  See details and how to joinNCT03527342